Immunos Therapeutics

Developer of immunotherapies for the treatment of cancer and autoimmune diseases

placeSchlieren, Zurich, Switzerland calendar_todayFounded 2013 groups31 employees language immunostherapeutics.com

Social engagement

Social engagement: 7K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include Gimv, Pfizer, Mission BioCapital, BioMedPartners.

Investor typeCountShare
Venture capital953%
Private equity16%
Angel & family office16%
Other / undisclosed635%

Recent activity

5 Jan 2026
Leadership hire
Chief Executive Officer
5 Jan 2026
Leadership hire
CEO
Coming soon